Thomas Herzog, MD
Advertisement
Articles by Thomas Herzog, MD
Advertisement
Latest Updated Articles
Ovarian Cancer: FDA Approved PARP InhibitorsJanuary 20th 2021
- Genetic Testing for Ovarian Cancer
January 20th 2021
- Role of Maintenance Therapy in Ovarian Cancer
January 20th 2021
- Future Directions for Treatment of Ovarian Cancer
January 20th 2021
- PAOLA-1 Trial
January 20th 2021
- Selecting Maintenance Therapy in Ovarian Cancer
January 20th 2021
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Camizestrant for ESR1-Mutated HR+/HER2– Advanced Breast Cancer
2
Novel Agent Earns FDA Breakthrough Therapy Designation for HPV+ Oropharyngeal Cancer
3
Debating Camizestrant, ctDNA Monitoring, and SERENA-6 in HR+ Breast Cancer
4
Saturated Fat Intake Linked to Greater Mortality in Nonmetastatic Prostate Cancer
5